This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Igarashi, J. Articles by Michel, T. Search for Related Content PubMed PubMed Citation Articles by Igarashi, J. Articles by Michel, T. Related Collections Related Article

(Circulation Research. 2008;102:630.)
© 2008 American Heart Association, Inc.

Editorials

The Enigma of Sphingosine 1-Phosphate Synthesis

A Novel Role for Endothelial Sphingosine Kinases

Junsuke Igarashi, Thomas Michel

From the Department of Cardiovascular Physiology (J.I.), Kagawa University, Kagawa, Japan; and Cardiovascular Division (T.M.), Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass.

Correspondence to Thomas Michel, MD, PhD, Cardiovascular Division, Brigham and Women’s Hospital, Thorn Building, Room 1210A, 75 Francis St, Boston, MA 02115; E-mail tmichel@rics.bwh.harvard.edu

See related article, pages 669–676

Key Words: vascular signaling • endothelial cells • sphingosine 1-phosphate • sphingosine kinase

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Sphingosine 1-phosphate (S1P) is well known as a key sphingolipid messenger molecule in the cardiovascular system, yet many fundamental features of its synthesis, transport, and action remain enigmatic. Indeed, the very name "sphingolipid" was coined to reflect the mysterious characteristics of this class of lipids. It is now well established (through the work of Timothy Hla and of many others subsequently) that S1P binds to and activates a family of G protein–coupled S1P receptors located in vascular endothelial cells, cardiac myocytes, blood platelets, and vascular smooth muscle cells (among other cell types) and elicits a broad range of physiological responses (reviewed elsewhere¹). In vascular endothelial cells, S1P elicits such diverse responses as cell survival, proliferation, angiogenesis, cell migration, permeability, and endothelial NO synthase activation. The intracellular signaling pathways stimulated by S1P have been extensively characterized, yet the cellular origins of S1P and the pathways for its transport and action in cardiovascular tissues remain incompletely understood. The concentration of S1P in normal human plasma is within the range of several hundred nanomolar, and this amphipathic lipid is highly protein bound, mostly to HDL and albumin.² Importantly, S1P receptors bind their ligand with an affinity in the nanomolar range; therefore, many important questions remain. What controls S1P binding to plasma proteins? Where does all this plasma S1P come from? Important clues to the latter question are provided in a recent report from the laboratory of Timothy Hla, published in this issue of Circulation Research³ and reporting the novel and important discovery: . . . [Full Text of this Article]

Related Article:

Vascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate

Krishnan Venkataraman, Yong-Moon Lee, Jason Michaud, Shobha Thangada, Youxi Ai, Herbert L. Bonkovsky, Nehal S. Parikh, Cheryl Habrukowich, and Timothy Hla
Circ. Res. 2008 102: 669-676. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

				J. S. Karliner Sphingosine kinase regulation and cardioprotection Cardiovasc Res, May 1, 2009; 82(2): 184 - 192. [Abstract] [Full Text] [PDF]